Sudeep Pharma Ltd. (SUDEEPPHRM) Share Price Hits Fresh 52-Week High

Sudeep Pharma Ltd. Share Price hits a fresh 52-week high at Rs 908.6, rising 2.68% today with a market cap of Rs 9,925.36 Cr.

Sudeep Pharma Ltd. Share Price reached a fresh 52-week high today, closing at Rs 880, up by 2.68% from the previous close of Rs 857. The stock opened at Rs 862 and peaked at Rs 908.6 during the day, marking a significant milestone. With a market capitalisation of Rs 9,925.36 crore, Sudeep Pharma Ltd. has captured investor attention. The event underscores the company's performance in the healthcare sector, although the data does not specify a particular catalyst for this rise.

Sudeep Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 880
Previous Close	Rs 857
Today's Change	+Rs 23 (+2.68%)
Day Open	Rs 862
Fresh 52-Week High	Rs 908.6
Day Low	Rs 857
Current Volume	13,980
Turnover	Rs 1.23 crore
Market Capitalisation	Rs 9,925.36 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) traded at Rs 880. versus the previous close of Rs 857, a rise of 2.68%. The stock opened at Rs 862, reached Rs 908.6, touched Rs 857. Reported volume was 13,980.

Today, Sudeep Pharma Ltd. Share Price opened at Rs 862 and reached a high of Rs 908.6, setting a fresh 52-week high. The stock closed at Rs 880, marking a 2.68% increase from the previous close of Rs 857. The day's low was Rs 857, with a turnover of Rs 1.23 crore and a volume of 13,980 shares. This price action indicates strong investor interest, aligning with the broader market trends in the healthcare sector.

Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 9,925.36 crore
P/E Ratio	39.17x
P/B Ratio	7.93x
ROE	28.21%
ROCE	26.35%

Sudeep Pharma Ltd. was valued at a P/E ratio of 39.17x, a P/B ratio of 7.93x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	39.17x
Benchmark Median P/E	20.13x
Benchmark Average P/E	73.73x
Benchmark P/E Range	0x to 3,417.8x
Company P/B Ratio	7.93x
Benchmark Median P/B	1.92x
Company ROE	28.21%
Benchmark Median ROE	10.73%
Company ROCE	26.35%
Benchmark Median ROCE	13.2%
Company Market Capitalisation	Rs 9,925.36 crore
Benchmark Median Market Cap	Rs 140.91 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 39.17x, which is above the benchmark median of 20.13x, a difference of +94.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of 28.21%, which is above the benchmark median of 10.73%, a difference of +162.91%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of 26.35%, which is above the benchmark median of 13.2%, a difference of +99.62%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Kwality Pharmaceuticals Ltd.	KPL	2,700.98	39.17	7.93	28.21	26.35
Beta Drugs Ltd.	BETA	2,475.7	58.88	9.32	18.65	22.17
Sai Parenteral's Ltd.	SAIPARENT	2,439.14	165.82	3.06	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,424.44	34.59	7	-2.6	16.92
Venus Remedies Ltd.	VENUSREM-BE	2,150.28	17.79	3.01	9.85	7.89

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 39.17x compared with the displayed peer median of 39.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 9,925.36 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Sudeep Pharma Ltd.

• Fresh 52-week high at Rs 908.6, indicating strong price momentum.
• High P/E and P/B ratios compared to sector medians, suggesting premium valuation.
• Strong ROE and ROCE, reflecting robust financial performance.
• Significant market cap within the healthcare sector.

About Sudeep Pharma Ltd.

Sudeep Pharma Ltd. operates in the healthcare sector, focusing on pharmaceuticals and drugs. The company has established itself as a key player with a substantial market cap of Rs 9,925.36 crore. Its strong financial metrics, including high ROE and ROCE, underscore its efficient operations and profitability. Sudeep Pharma Ltd. continues to attract investor interest due to its robust market position and performance.

Track Sudeep Pharma Ltd. Share Price on Univest

Use Sudeep Pharma Ltd. (SUDEEPPHRM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Sudeep Pharma Ltd. Share Price, technical indicators, fundamental ratios, shareholding patterns, and market insights on Univest. Stay updated with the latest 52-week levels and comprehensive market analysis.

Frequently Asked Questions

What is the current share price of Sudeep Pharma Ltd.?

Ans. The current share price of Sudeep Pharma Ltd. is Rs 880, reflecting a 2.68% increase from the previous close of Rs 857. The stock moved 2.68% during the session. The intraday range extended from Rs 857 to Rs 908.6.

What was the 52-week high for Sudeep Pharma Ltd.?

Ans. The 52-week high for Sudeep Pharma Ltd. was Rs 908.6, achieved today, marking a significant milestone for the company. The stock moved 2.68% during the session. The intraday range extended from Rs 857 to Rs 908.6.

How does Sudeep Pharma Ltd.'s P/E ratio compare to the sector?

Ans. Sudeep Pharma Ltd.'s P/E ratio of 39.17 is above the sector median of 20.13, indicating a higher valuation compared to its peers. The company trades at a P/E ratio of 39.17x.

What is the market capitalisation of Sudeep Pharma Ltd.?

Ans. Sudeep Pharma Ltd. has a market capitalisation of Rs 9,925.36 crore, positioning it as a significant player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 39.17x.

How does Sudeep Pharma Ltd.'s ROE compare to the sector average?

Ans. Sudeep Pharma Ltd.'s ROE of 28.21% is well above the sector average of 15.02%, highlighting its strong profitability. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.

What is the P/B ratio of Sudeep Pharma Ltd.?

Ans. The P/B ratio of Sudeep Pharma Ltd. is 7.93, significantly higher than the sector median of 1.92, indicating a premium valuation. The company trades at a P/E ratio of 39.17x.

Who are Sudeep Pharma Ltd.'s main competitors?

Ans. Sudeep Pharma Ltd.'s main competitors include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., and Sai Parenteral's Ltd., among others. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Sai Parenteral's Ltd.

How does Sudeep Pharma Ltd.'s ROCE compare to the sector?

Ans. Sudeep Pharma Ltd.'s ROCE of 26.35% is significantly higher than the sector median of 13.2%, indicating efficient capital utilization. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.